Parameters | Intervention group (n = 120) | Control group (n = 100) | ||||||
---|---|---|---|---|---|---|---|---|
Sex (male/female) [n] | 55 (46%) / 65 (54%) | 46 (46%) / 54 (54%) | ||||||
Age [years] | 62 ± 11 | 60 ± 9 | ||||||
Baseline (n = 120) | End (n = 93) | ∆ | p | Baseline (n = 100) | End (n = 83) | ∆ | p | |
Weight [kg] | 98 ± 19 | 96 ± 19 | -1.2 ± 4.7 | 0.0001 | 96 ± 22 | 96 ± 24 | -0.7 ± 2.6 | 0.014 |
Body mass index [kg/m2] | 34.1 ± 6.5 | 33.5 ± 6.5 | -0.4 ± 1.6 | 0.0001 | 33.2 ± 6.3 | 33.2 ± 6.5 | -0.3 ± 0.9 | 0.007 |
Systolic blood pressure [mmHg] | 134 ± 15 | 132 ± 13 | -2 ± 15 | ns | 135 ± 17 | 136 ± 17 | 2 ± 14 | ns |
Diastolic blood pressure [mmHg] | 80 ± 8 | 79 ± 8 | -0.6 ± 10 | ns | 80 ± 9 | 80 ± 8 | -0,3 ± 9 | ns |
Fasting blood glucose [mg/dl] | 136 ± 39 | 127 ± 37 | -8 ± 35 | 0.041 | 130 ± 39 | 130 ± 37 | -3 ± 24 | ns |
Total cholesterol [mg/dl] | 207 ± 43 | 204 ± 44 | -3 ± 23 | ns | 202 ± 45 | 201 ± 45 | -2 ± 18 | ns |
HDL cholesterol [mg/dl] | 50 ± 14 | 51 ± 14 | 0 ± 7 | ns | 48 ± 11 | 49 ± 12 | 0 ± 5 | ns |
LDL cholesterol [mg/dl] | 125 ± 35 | 125 ± 36 | 0 ± 23 | ns | 124 ± 50 | 120 ± 42 | 4 ± 26 | ns |
Triglycerides [mg/dl] | 200 ± 123 | 198 ± 114 | 2 ± 65 | ns | 234 ± 251 | 238 ± 27 | 5 ± 69 | ns |
Physical activity [%] | 42 ± 19 | 59 ± 17 | 12 ± 12 | <0.0001 | 43 ± 21 | 46 ± 19 | 4 ± 10 | 0.002 |
Treatment with Metformin [%] | 73 | 72 | -1 | ns | 78 | 81 | 3 | ns |
Treatment with DPP-4 inhibitors [%] | 16 | 16 | 0 | ns | 19 | 19 | 0 | ns |